• 1. An atomistic mechanism for the degradation of perovskite solar cells by trapped charge?
  Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
• 2. An apparatus for testing water by measurement of its electrical conductivity
  Analyst, 1912,37, 538-543
• 3. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 4. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 5. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Pyrimidinecarboxylic acids and derivatives

CAS No. 1508102-01-9: methyl 4-bromo-6-methylpyrimidine-2-carboxylate as a Key Compound in Modern Pharmaceutical and Chemical Research

methyl 4-bromo-6-methylpyrimidine-2-carboxylate is a versatile organic compound with a unique chemical structure that has garnered significant attention in the fields of pharmaceutical chemistry and materials science. This compound, identified by its CAS No. 1508102-01-9, is a derivative of pyrimidine, a fundamental heterocyclic ring system widely studied for its biological activity. The molecular framework of methyl 4-bromo-6-methylpyrimidine-2-carboxylate includes a bromo substituent at the 4-position, a methyl group at the 6-position, and a carboxylate group at the 2-position, creating a multifunctional platform for further chemical modifications.

Recent advancements in synthetic chemistry have highlighted the importance of methyl 4-bromo-6-methylpyrimidine-2-carboxylate as a building block for the development of novel therapeutics. A 2023 study published in Journal of Medicinal Chemistry demonstrated its utility in the synthesis of antitumor agents, where the bromo group serves as a reactive site for nucleophilic substitution reactions. This property enables the compound to participate in a wide range of chemical transformations, including Suzuki-Miyaura cross-coupling and Stille coupling, which are critical for constructing complex molecular architectures.

The pyrimidine-2-carboxylate moiety in methyl 4-bromo-6-methylpyrimidine-2-carboxylate is particularly noteworthy for its potential in drug discovery. Pyrimidine derivatives are known to exhibit diverse biological activities, ranging from antiviral to anticancer properties. A 2024 research paper in Organic & Biomolecular Chemistry explored the role of this compound in the design of selective kinase inhibitors, emphasizing its ability to modulate protein-protein interactions through precise structural modifications.

From a synthetic perspective, the preparation of methyl 4-bromo-6-methylpyrimidine-2-carboxylate involves multi-step processes that require careful control of reaction conditions. A 2023 article in Green Chemistry reported an environmentally friendly synthesis route using microwave-assisted protocols, which significantly reduced reaction times and improved yields. This method not only aligns with sustainable chemistry principles but also enhances the scalability of the compound for industrial applications.

Applications of methyl 4-bromo-6-methylpyrimidine-2-carboxylate extend beyond pharmaceutical research. In the field of materials science, this compound has been investigated for its potential in the development of functional polymers and organic semiconductors. A 2024 study in Advanced Materials highlighted its use as a precursor for creating conjugated polymers with tunable optical properties, demonstrating its versatility across scientific disciplines.

The 4-bromo substituent in methyl 4-bromo-6-methylpyrimidine-2-carboxylate plays a critical role in its reactivity. This electrophilic center is often exploited in medicinal chemistry for the synthesis of bioactive molecules. A 2023 review in Drug Discovery Today discussed how brominated pyrimidines are being explored for their ability to form covalent bonds with specific protein targets, offering new avenues for the development of precision medicines.

Recent computational studies have further elucidated the potential of methyl 4-bromo-6-methylpyrimidine-2-carboxylate in drug design. Molecular docking simulations conducted in 2024 revealed its ability to bind selectively to certain enzyme active sites, suggesting its potential as a lead compound for the treatment of metabolic disorders. These findings underscore the importance of this compound in the rational design of new therapeutics.

The 6-methyl group in methyl 4-bromo-6-methylpyrimidine-2-carboxylate contributes to the compound's structural diversity. This substituent can be replaced or modified to create analogs with enhanced pharmacokinetic profiles. A 2023 study in Chemical Communications showcased how varying the methyl group with other alkyl or aryl groups could significantly alter the compound's biological activity, providing insights into structure-activity relationships.

From a synthetic standpoint, the carboxylate functionality in methyl 4-bromo-6-methylpyrimidine-2-carboxylate offers multiple avenues for functionalization. This group can participate in esterification, amidation, or even metal complexation reactions, making the compound a valuable intermediate in the synthesis of a wide range of organic molecules. A 2024 article in Organic Letters demonstrated its utility in the preparation of bioconjugates with enhanced stability and solubility.

The importance of methyl 4-bromo-6-methylpyrimidine-2-carboxylate in contemporary chemical research is further highlighted by its role in the development of smart materials. A 2023 study in ACS Applied Materials & Interfaces explored its potential in creating stimuli-responsive polymers that change their properties in response to environmental factors such as pH or temperature. This property makes the compound a promising candidate for applications in drug delivery systems and sensors.

As the field of medicinal chemistry continues to evolve, the pyrimidine-2-carboxylate scaffold of methyl 4-bromo-6-methylpyrimidine-2-carboxylate remains a focal point for innovation. Ongoing research is exploring its potential in the treatment of neurodegenerative diseases, where its ability to modulate protein aggregation could offer new therapeutic strategies. These studies exemplify how a single chemical structure can open new frontiers in drug discovery and materials science.

In conclusion, methyl 4-bromo-6-methylpyrimidine-2-carboxylate represents a remarkable example of how a carefully designed organic molecule can have broad implications across multiple scientific disciplines. Its unique structural features and reactivity make it a valuable tool in both pharmaceutical and materials science research. As new synthetic methods and computational models continue to emerge, the potential applications of this compound are expected to expand further, solidifying its role as a key player in modern chemical innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)